Back
Open Access

Panel discussion.

logo

Session: Discussing clinical implications of glucagon-like peptide-1 receptor agonists
Topic: Pharmacotherapy
Speaker: Doctor K. Connelly (Toronto, CA) Doctor M. Lehrke (Aachen, DE) Doctor N. Pagidipati (Durham, US)
Sponsored by Novo Nordisk A/S
Event: ESC Congress 2020

Congress Presentation

About the speakers

Doctor Kim Connelly

St. Michael's Hospital, Toronto (Canada)
1 presentation
0 follower

Doctor Michael Lehrke

RWTH University Hospital Aachen, Aachen (Germany)
0 follower

Doctor Neha Pagidipati

Duke Clinical Research Institute, Durham (United States of America)
0 follower

4 more presentations in this session

Welcome and introduction.

Speaker: Professor K. Connelly (Toronto, CA)

Access
Video
Thumbnail

Highlighting cardiovascular benefits of glucagon-like peptide-1 receptor agonists.

Speaker: Professor K. Connelly (Toronto, CA)

Access
Video
Thumbnail

Evaluating cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists.

Speaker: Doctor M. Lehrke (Aachen, DE)

Access
Video
Thumbnail

Exploring the gap between data and clinical practice.

Speaker: Assistant Professor N. Pagidipati (Durham, US)

Access
Video
Thumbnail

Access the full session

Discussing clinical implications of glucagon-like peptide-1 receptor agonists

Speakers: Doctor K. Connelly, Doctor M. Lehrke, Doctor N. Pagidipati, Professor K. Connelly, Professor K. Connelly...
Access
Video
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb